Morgane Bomsel

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 50 publications

Cannabidiol prevents mucosal HIV-1 transmission by targeting Langerhans cells, dendritic cells, macrophages and T-cells.

Cannabidiol prevents mucosal HIV-1 transmission by targeting Langerhans cells, dendritic cells, macrophages and T-cells.

Journal: Mucosal immunology

Published: January 05, 2026

Direct pharmacological AMPK activation inhibits mucosal SARS-CoV-2 infection by reducing lipid metabolism, restoring autophagy flux and the type I IFN response.

Direct pharmacological AMPK activation inhibits mucosal SARS-CoV-2 infection by reducing lipid metabolism, restoring autophagy flux and the type I IFN response.

Journal: Journal of virology

Published: June 12, 2025

IgA-dependent cell phagocytosis of HIV-infected cells elicits cross-presentation to CD8+T cells and immune memory in effector monocytes.

IgA-dependent cell phagocytosis of HIV-infected cells elicits cross-presentation to CD8+T cells and immune memory in effector monocytes.

Journal: Mucosal immunology

Published: February 19, 2025

The conformational epitope of a gp41-specific mucosal protective IgA binds to the HIV-1 envelope and neutralizes infection.

The conformational epitope of a gp41-specific mucosal protective IgA binds to the HIV-1 envelope and neutralizes infection.

Journal: Acta pharmacologica Sinica

Published: January 08, 2025

Erratum for Barbosa Bomfim et al., "CGRP inhibits SARS-CoV-2 infection of bronchial epithelial cells, and its pulmonary levels correlate with viral clearance in critical COVID-19 patients".

Erratum for Barbosa Bomfim et al., "CGRP inhibits SARS-CoV-2 infection of bronchial epithelial cells, and its pulmonary levels correlate with viral clearance in critical COVID-19 patients".

Journal: Journal of virology

Published: December 10, 2024

Targeting the SARS-CoV-2 reservoir in long COVID.

Targeting the SARS-CoV-2 reservoir in long COVID.

Journal: The Lancet. Infectious diseases

Published: September 16, 2024

CGRP inhibits SARS-CoV-2 infection of bronchial epithelial cells, and its pulmonary levels correlate with viral clearance in critical COVID-19 patients.

CGRP inhibits SARS-CoV-2 infection of bronchial epithelial cells, and its pulmonary levels correlate with viral clearance in critical COVID-19 patients.

Journal: Journal of virology

Published: August 20, 2024

HIV-1 inhibits IFITM3 expression to promote the infection of megakaryocytes.

HIV-1 inhibits IFITM3 expression to promote the infection of megakaryocytes.

Journal: Journal of molecular cell biology

Published: July 31, 2023

Protocol to detect infectious SARS-CoV-2 at low levels using in situ hybridization techniques.

Protocol to detect infectious SARS-CoV-2 at low levels using in situ hybridization techniques.

Journal: STAR protocols

Published: June 01, 2023

TRPV1 activation in human Langerhans cells and T cells inhibits mucosal HIV-1 infection via CGRP-dependent and independent mechanisms.

TRPV1 activation in human Langerhans cells and T cells inhibits mucosal HIV-1 infection via CGRP-dependent and independent mechanisms.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: May 22, 2023

Editorial: Mucosal immunity to HIV and SARS-CoV-2 infection and vaccination.

Editorial: Mucosal immunity to HIV and SARS-CoV-2 infection and vaccination.

Journal: Frontiers in immunology

Published: April 06, 2023

Editorial: Platelet and megakaryocyte dysfunctions in infectious diseases.

Editorial: Platelet and megakaryocyte dysfunctions in infectious diseases.

Journal: Frontiers in immunology

Published: February 27, 2023

Showing 1-12 of 50

Last Updated: 09/26/2026